Background. Unlike the vast amount of animal data available on the recellularization of allogenic decellularized heart valves (DHV), there have only been sporadic histological reports on such grafts in humans.
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Decellularized human heart valves (DHV) have been approved by multiple competent authorities for routine use. To date, several hundred DHV have been implanted for aortic and pulmonary valve replacement and have yielded promising mid-term results. [1] [2] [3] [4] [5] Little, however, is known about the important process of DHV recellularization by the recipient`s cell populations. Even though a generally low level of immunogenicity has been demonstrated for DHV 6, 7 , infiltration by neutrophils, lymphocytes and macrophages may occur and can only be reliably assessed by histology. Furthermore, true long-term durability of DHV can only be expected if recellularization with endothelial cells, smooth muscle cells and fibroblasts occurs to an extent large enough to enable elastic fibers, collagen matrix structure, proteoglycans and other extracellular proteins to continuously regenerate.
In contrast to the vast amount of animal data available on the recellularization of decellularized allogenic heart valves, so far only sporadic histological reports on decellularized grafts have been put forward in humans. [8] [9] [10] [11] Specifics of tissue processing, methods and results of histological analyzes albeit were heterogeneous, ranging from infiltration by inflammatory cells and severe calcification to good preservation of the matrix and widespread non-inflammatory repopulation.
This study aims to establish more histological evidence on the extent of spontaneous in-vivo recellularization of detergent based decellularized, non-cryopreserved and non-seeded allografts.
Patients and Methods
The detergent based method used for decellularization of homografts has been described before. 1 After 2013 a spin-off company from Hannover Medical School provided the decellularisation service following market approval for DPH and DAH (PEI.G.11766.01.1
and PEI.G.11634.01.1). Completeness of decellularization was assessed via histology and DNA content for each homograft before release.
The postoperative clinical course of all patients receiving either a decellularized pulmonary homograft (DPH) for pulmonary valve replacement (PVR) or a decellularized aortic homograft (DAH) for aortic valve replacement (AVR) have been prospectively followed M A N U S C R I P T
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Repopulation of cell-free homografts 4 since 1/2005. Approval was given by all local ethics committees before start of the studies as well as informed consent by all participants or parents.
All explanted homografts from 12/2010 to 4/2017 were secured for histo-pathological analysis. Specimens obtained during planned staged palliative operations were also harvested, when possible without performing any additional incision to the existing graft.
Histological assessment
Two experienced cardiac pathologists (> 8 years after board examination) independently evaluated the structure of the valve wall and cusp (when available) as well as the amount and type of recellularization, using a semi-quantitative score in integer numbers ranging from 0-6 points in relation to published normal histological findings.
12
Formalin-fixed and paraffin-embedded tissue was cut to 1µm slices at a routine microtome.
For standard and immuno-histochemistry the cut slices were stained at a routine automated tissue-stainer (Ventana Ultra, Roche, Basel, Switzerland) according the manufacturer's specification. Antibody details are provided as Supplemental Table 1 . Standard histological analysis was performed using Haemotoxylin and Eosin (HE) and Elastica van Gieson (EvG) staining. Scores were allocated for the valves as follows: Destruction of the elastic fibers and collagen structure was graded with 0 points, poorly maintained matrix structure with 2 points, maintained appropriate matrix structure with 4 points and a normal or near-normal matrix structure was allocated 6 points. A normal or near-normal overall cell count within the homograft resulted in 6 points, moderate recellularization in 4 points, poor recellularization in 2 points and no recellularization in 0 points.
We also differentiated cell types within the explanted tissues by applying uniform automated 
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A total score was calculated for each patient using the results of 2 anatomical stainings (as not all specimens provided material for separate wall and cusp analysis) and 5 immunological
stainings. An optimal result in these 7 categories would be calculated as a total of 42 points and classified as 100%. Overall relative results were calculated for each specimen using the mean overall point score of both observers.
Statistical analysis
Statistics on decellularized homografts were performed using SPSS 23 (IBM Corporation, Somer, NY). Summaries of the numeric data are given as means and standard deviation; a probability value of 0.05 or less was considered statistically significant. Inter-rater and intrarater agreement (Kappa) was calculated with 95% confidence interval as reported by Fleiss.
Kappa`s of 0.61-0.80 were considered good and 0.81-1.0 as very good.
No correlations between implant duration and recellularization rate were calculated due to the significant heterogeneity of the small study cohort with respect to age at implantation, reasons for re-operation and DHV position.
Results
A total of 364 decellularized, non-seeded and non-cryopreserved homografts (236 pulmonary and 128 aortic) were implanted between 1/2005 and 4/2017. Follow-up was 100%, comprising 888.1 patient years and >2700 examinations. Details on patient demographics, homograft size and overall hemodynamic performance are provided in Table 1 .
Within this 12-year period 8 decellularized homografts were explanted, leading to freedom from explantation of 96.1% for DAH and 98.7% for DPH. One DAH was not available for standardized histological assessment; this case involving the rupture of the native ascending aorta due to an Aspergillus infection has been reported previously. 1 Eleven specimens (7 explants, 4 biopsies) were available for histological assessment, 6
specimens derived from DAH, 5 from DPH. Details of specimens, patient characteristics and clinical situation are provided within Table 2 .
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Reasons for re-operation
Reasons for re-operation included scheduled re-operation in 2 out of 11 patients, stenosis either at subvalvular, valvular or supravalvular level in 3 patients and endocarditis/suspected endocarditis in 5 patients. Intraoperative aspects are provided in Figure 1 . One young patient underwent successful heart transplantation 8 months after DAH implantation due to preexisting myocardial failure, which did not improve despite DAH implantation and normal homograft function ( the homograft, which showed only mild alteration, and was followed by standard antibiotic treatment. At 12 months of follow up, the patient remains free of recurrent endocarditis.
The overall endocarditis rate for decellularized homografts, including the unclear cases described above, was calculated as 0.68% per patient-year (5+1 in 881.1 patient-years).
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Spectrum of spontaneous recellularization
There was good agreement between the two readers as reflected by an inter-agreement weighted Kappa of 0.783 (95% CI 0.707 to 0.859) and an intra-observer agreement weighted Kappa of 0.670 (95% CI 0.502 to 0.839; 3 randomly selected patients evaluated by D.J. > 9 months after the initial analysis). Supplemental Tables 2 and 3 show the evaluation of matrix (and cusp) structure, amount and type of recellularization for each patient as graded by the two pathologists. The overall relative histological score was 60% (±16.1) compared with normal tissue. Results in non-endocarditis cases were significantly better with 76% (±4.3%,)
vs. 48% (±7.3%, p=.0004 Mann-Whitney-U-Test for independent samples).
The patient with the highest histological score was an infant who had received a 10 mm DAH implantation at 6 weeks of age, as reported. 4 There was good overall recellularization of the graft with mesenchymal cells, smooth muscle cells and myofibroblasts ( Figure 3A -G).
Almost no immune cells were found, resulting in a score of 34 points (81%) out of a possible maximum of 42 points. Figure 3H depicts a significant amount of intracellular pro-collagen present in cells with a fibroblastic morphological appearance within the aortic sinus 4.5 years after implantation.
The lowest histological score was 41%, which was determined for two patients. One young adult female patient suffered a severe Staph. aureus endocarditis, which led to a massive infiltration by immune-competent cells and the destruction of the DPH to an extent close to perforation. The other patient, an adult patient, who received a DPH for PVR following a former Ross operation, developed progressive valvular stenosis despite pliable cusps. At explantation 12 months postoperatively, the graft diameter had shrunken, whereas the wall and cusps macroscopic appearance were almost normal ( Figure 1D ). The wall structure was shown to be severely compromised and there was prominent infiltration by granulocytes, T- Microbiological cultures and PCR were both negative.
In 2 patients with hypoplastic left heart syndrome (Patients 4 and 6), decellularized homografts were used for the augmentation of their hypoplastic aortic arches. In one patient, a DAH was used to replace the ascending aorta; in the other a DPH was used for arch reconstruction. Biopsies were taken during a scheduled Glenn operation at 9 and 7 months, respectively. Interestingly, despite normal intraoperative findings in both homografts, the pulmonary homograft's matrix was less well preserved after 7 months in the systemic position (70 vs. 79%). The inner third of the allograft wall was sparsely populated in both patients indicating a) preferred cell invasion from the adventitial side and b) that a period of several months may be needed for recellularization.
Comment
The longevity of any tissue-engineered heart valve, be it artificial, xenogenic or allogeneic in origin, depends on the recipient's immunogenic response, which can result in a chronic inflammatory process and subsequent structural valve disease. A low immune response, on the other hand, is a prerequisite for the anticipated invasion of non-inflammatory autologous cell populations, which may hold the potential to promote graft regeneration.
Immune systems vary considerably between species. Transferring approaches from successful animal models to humans can have dramatically negative results. 13 As things stand, there is currently no valid animal model, which would allow adequate prediction of the performance of tissue-engineered grafts in humans. However, undertaking planned heart valve biopsies in humans is not an option for obvious ethical reasons. Consequently, conclusions can only be derived in the rare cases of scheduled procedures or unplanned re-operations.
Extent and speed of spontaneous recellularization
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This current analysis of the largest cohort published to date adds important information as it provides insights into the extent and pace of recellularization processes in decellularized matrices in a real-life setting. Grafts obtained during the first 12 months after implantation
were not evenly repopulated with less recellularization in the inner parts; no difference was found between DAH and DPH as might have been expected due to the thinner wall diameters of DPH. This finding has implications for size selection, as autologous regeneration of the allogenic matrix may not be sufficient in the first 9-12 months, thereby necessitating oversizing in growing patients. 
Immune system mediated graft failure
One adult patient, following DPH implantation in a post Ross-procedure situation, experienced early and steadily progressive graft failure due to diameter shrinkage in the whole graft, despite the cusps indicating normal performance in echocardiography.
Histological analysis showed severe damage of the matrix structure and a high number of infiltrating immune competent cells without any clinical or microbiological evidence for bacterial endocarditis. Although we did not find the classical signs of a T-cell mediated graft rejection we grade this case as a potentially immune system-mediated graft failure. We observed similar but milder clinical courses in some pediatric DPH patients, who in part required balloon valvuloplasty. 7 Da Costa also reported shrinkage of a decellularized pulmonary homograft in a pediatric patient 8 years after implantation in the absence of classical rejection signs or calcification. 15 
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This indicates that despite elimination of about 99% of donor DNA during DHV processing some patients may still elicit an immune response. It is possible that remnants from the decellularization process itself may also be present and pathogenic, albeit unlikely due to the multiple washing steps after detergent decellularization. Further research should be directed towards detecting the mechanisms of such immune reactions. As fresh DHV samples become available during processing and due to recently established prolonged storage options, matching against patient serum prior to implantation presents a possible option to avoid such graft failure in the future.
Endocarditis
The observed risk for endocarditis in DHV is in the reported range of 0.5-1% per patient-year for different types of heart valve prostheses, which is also supported by the low endocarditis incidence reported by Da Costa for pediatric pulmonary valve replacement. 15 The risk for endocarditis using DPV for PVR is significantly lower than the reported incidence for bovine jugular vein conduits. 16 A interesting finding of our study was that 50% of the endocarditis cases were associated with prosthetic material. As there is a well-established increased risk of endocarditis when using artificial material, we recommend avoiding the use of prosthetic material in combination with DHV wherever possible as well as lifelong endocarditis prophylaxis for our patients.
Limitations
The results observed are likely to represent the poorer 'performers' within the recellularization spectrum as >80 % of the specimens were acquired in pathological situations, such as flow turbulence or infection. In addition, important aspects such as direct proof of matrix regeneration, e.g. by newly synthesized collagen integration and analysis of the extracellular substance, are lacking in our descriptive analysis, but would be extremely advantageous. Limitations are also given by the "eye-based" semi-quantitative scoring algorithm and in the specimens derived from biopsies as for obvious reasons these were not performed at leaflet levels and as such small samples do have limited information about the rest of the implanted homograft.
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Finally, decellularization protocols and matrix structures can vary significantly between products and caution should therefore be applied in interpreting the results and transferring them to other decellularization techniques. 13, 17 In conclusion, significant in-vivo recellularization with non-inflammatory cells was observed in this study, which represents the largest human histological analysis of decellularized allografts conducted to date. Spontaneous recellularization appears to require multiple months, which correspondingly has an impact on size selection for fast growing young patients. One case of immune system mediated early graft failure was observed without the classical signs of a T-cell mediated rejection. Further research should be directed towards detecting the mechanisms of such immune reactions.
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